Logo image of MRVL.CA

MARVEL BIOSCIENCES CORP (MRVL.CA) Stock Price, Quote, News and Overview

TSX-V:MRVL - TSX Venture Exchange - CA57384M1077 - Common Stock - Currency: CAD

0.085  0 (0%)

MRVL.CA Quote, Performance and Key Statistics

MARVEL BIOSCIENCES CORP

TSX-V:MRVL (5/5/2025, 7:00:00 PM)

0.085

0 (0%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High0.18
52 Week Low0.06
Market Cap3.81M
Shares44.80M
Float32.64M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO02-28 2019-02-28


MRVL.CA short term performance overview.The bars show the price performance of MRVL.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

MRVL.CA long term performance overview.The bars show the price performance of MRVL.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of MRVL.CA is 0.085 CAD. In the past month the price decreased by -32%. In the past year, price decreased by -37.04%.

MARVEL BIOSCIENCES CORP / MRVL Daily stock chart

About MRVL.CA

Company Profile

MRVL logo image Marvel Biosciences Corp. is a biotechnology company that utilizes a drug redevelopment approach to drug development. The company is headquartered in Calgary, Alberta. The company went IPO on 2019-02-28. The firm develops new synthetic chemical derivatives of the original approved drug for the new disease indication. The company has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression and anxiety, Alzheimer's, attention deficit hyperactivity disorder (ADHD)), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The firm's lead compound, MB-204, is a fluorinated derivative of Istradefylline. The firm is engaged in developing MB-204 for diseases other than Parkinson's disease, specifically depression, Alzheimer’s Disease and liver fibrosis due to non-alcoholic steatohepatitis (NASH). Its wholly owned subsidiary is Marvel Biotechnology Inc.

Company Info

MARVEL BIOSCIENCES CORP

Suite 420, 505 8th Avenue S.W.

Calgary ALBERTA CA

Employees: 0

MRVL Company Website

MRVL Investor Relations

Phone: 14037702469

MARVEL BIOSCIENCES CORP / MRVL.CA FAQ

What is the stock price of MARVEL BIOSCIENCES CORP today?

The current stock price of MRVL.CA is 0.085 CAD.


What is the ticker symbol for MARVEL BIOSCIENCES CORP stock?

The exchange symbol of MARVEL BIOSCIENCES CORP is MRVL and it is listed on the TSX Venture Exchange exchange.


On which exchange is MRVL.CA stock listed?

MRVL.CA stock is listed on the TSX Venture Exchange exchange.


What is MARVEL BIOSCIENCES CORP worth?

MARVEL BIOSCIENCES CORP (MRVL.CA) has a market capitalization of 3.81M CAD. This makes MRVL.CA a Nano Cap stock.


How many employees does MARVEL BIOSCIENCES CORP have?

MARVEL BIOSCIENCES CORP (MRVL.CA) currently has 0 employees.


What are the support and resistance levels for MARVEL BIOSCIENCES CORP (MRVL.CA) stock?

MARVEL BIOSCIENCES CORP (MRVL.CA) has a resistance level at 0.1. Check the full technical report for a detailed analysis of MRVL.CA support and resistance levels.


Should I buy MARVEL BIOSCIENCES CORP (MRVL.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does MARVEL BIOSCIENCES CORP (MRVL.CA) stock pay dividends?

MRVL.CA does not pay a dividend.


What is the Price/Earnings (PE) ratio of MARVEL BIOSCIENCES CORP (MRVL.CA)?

MARVEL BIOSCIENCES CORP (MRVL.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).


MRVL.CA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

MRVL.CA Financial Highlights

Over the last trailing twelve months MRVL.CA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 45.57% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -616.57%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%52.31%
Sales Q2Q%N/A
EPS 1Y (TTM)45.57%
Revenue 1Y (TTM)N/A

MRVL.CA Ownership and Analysts


Ownership
Inst OwnersN/A
Ins Owners15.23%
Short Float %N/A
Short RatioN/A
Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A